Nello Mainolfi is Chief Executive Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 666,195 shares of KYMR, which is worth approximately $43.3 Million. The most recent transaction as insider was on Apr 09, 2021, when has been sold 22,794 shares (Common Stock) at a price of $33.89 per share, resulting in proceeds of $772,489. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 666K
0.86% 3M change
2.5% 12M change
Total Value Held $43.3 Million

Nello Mainolfi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 09 2021
SELL
Open market or private sale
$772,489 $33.89 p/Share
22,794 Reduced 5.71%
376,199 Common Stock
Apr 09 2021
BUY
Exercise of conversion of derivative security
$47,412 $2.08 p/Share
22,794 Added 5.4%
398,993 Common Stock
Apr 08 2021
SELL
Open market or private sale
$350,052 $35.22 p/Share
9,939 Reduced 2.57%
376,199 Common Stock
Apr 08 2021
BUY
Exercise of conversion of derivative security
$20,673 $2.08 p/Share
9,939 Added 2.51%
386,138 Common Stock
NM

Nello Mainolfi

Chief Executive Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR